AstraZeneca completes balcinrenone/dapagliflozin PK study; posts two new observational trialsOct 23Weekly roundup, 12 itemsabemaciclibAstraZeneca
AstraZeneca halts eVOLVE-Lung02 trial of volrustomig in lung cancerAug 17Clinical readoutAstraZenecavolrustomig